Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Neurofibrosarcoma × pegfilgrastim × Clear all

Sponsor

Conditions

Breast Neoplasms 24 Lymphoma 14 Neutropenia 9 Lymphoma, Large B-Cell, Diffuse 7 Leukemia 7 Neoplasms 6 Lymphoma, Follicular 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Triple Negative Breast Neoplasms 4 Hodgkin Disease 4 Chemotherapy-induced Neutropenia 4 Carcinoma, Non-Small-Cell Lung 4 Urinary Bladder Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Ovarian Neoplasms 3 Multiple Myeloma 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Mantle-Cell 3 Lymphoma, B-Cell, Marginal Zone 3 Colorectal Neoplasms 3 Breast Neoplasms, Male 3 Waldenstrom Macroglobulinemia 2 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Rectal Neoplasms 2 Prostatic Neoplasms 2 Neoplasm Metastasis 2 Lymphoma, T-Cell, Peripheral 2 Lung Neoplasms 2

Interventions

Doxorubicin 4 pazopanib 3 Ifosfamide 3 Sorafenib 2 Sirolimus 2 Radiotherapy 2 Etoposide 2 thymoglobulin 1 temsirolimus 1 tazemetostat 1 romidepsin 1 pexidartinib 1 lorvotuzumab mertansine 1 liposomal doxorubicin 1 indolepropanol phosphate 1 fludarabine phosphate 1 Watchful Waiting 1 Thiotepa 1 Tacrolimus 1 Sunitinib 1 Stem Cell Transplantation 1 STA 9090 1 Razoxane 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Radiation 1 Polymerase Chain Reaction 1 Observation 1 Neoadjuvant Therapy 1 Mycophenolic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡